Prevalence, incidence and relative risk of cardiovascular disease risk factors in adults with atopic dermatitis: A systematic review von Thyssen, Jacob P., Ross Terres, Jorge A., Pierce, Evangeline J., Feely, Meghan A., Silverberg, Jonathan I.

Volltext

Two Cases of Lichen Striatus with Prolonged Active Phase von Feely, Meghan A., Silverberg, Nanette B.

Volltext

Inappropriate Application of Nodule Management Guidelines in Radiologist Reports Before and After Revision of Exclusion Criteria von FEELY, Meghan A, HARTMAN, Thomas E

Volltext

Cutaneous lymphatics and chronic lymphedema of the head and neck von Feely, Meghan A., Olsen, Kerry D., Gamble, Gail L., Davis, Mark D., Pittelkow, Mark R.

Volltext

Novel psoriasis therapies and patient outcomes, part 2: biologic treatments von Feely, Meghan A, Smith, Barry L, Weinberg, Jeffrey M

Volltext

Novel psoriasis therapies and patient outcomes, part 1: topical medications von Feely, Meghan A, Smith, Barry L, Weinberg, Jeffrey M

Volltext

Novel psoriasis therapies and patient outcomes, Part 3: Systemic medications von Feely, Meghan A, Smith, Barry L, Weinberg, Jeffrey M

Volltext

Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trial... von Deodhar, Atul, Blauvelt, Andrew, Lebwohl, Mark, Feely, Meghan, Kronbergs, Andris, Eberhart, Nadezhda, Zhu, Danting, Inman, Elsa, Grace, Elsie, Holzkaemper, Thorsten, Rahman, Proton, Marzo-Ortega, Helena, Papp, Kim A, Merola, Joseph F, Gottlieb, Alice B, Schwartzman, Sergio

Volltext

Using present-day observations to detect when anthropogenic change forces surface ocean carbonate chemistry outside preindustrial bounds von Sutton, Adrienne J, Sabine, Christopher L, Feely, Richard A, Cai, Wei-Jun, Cronin, Meghan F, McPhaden, Michael J, Morell, Julio M, Newton, Jan A, Noh, Jae-Hoon, Ólafsdóttir, Sólveig R, Salisbury, Joseph E, Send, Uwe, Vandemark, Douglas C, Weller, Robert A

Volltext

43015 Ixekizumab real-world effectiveness at 24 weeks in patients with psoriasis: Data from the United States Taltz Customer Support Program von Gottlieb, Alice, Burge, Russel, Malatestinic, William, Zhu, Baojin, Guo, Jiaying, Zhao, Yunyang, McCormack, Julie, Kimel, Miriam, Feely, Meghan, Merola, Joseph

Volltext

43054 The Psoriasis Study of Health Outcomes (PSoHO) in biologic-naïve and -experienced patients: A post-hoc analysis of patients receiving treatment according to US labels von Khattri, Saakshi, Gooderham, Melinda, Reich, Adam, Lynde, Charles, Malatestinic, William, Reed, Catherine, Brnabic, Alan, Feely, Meghan, Gallo, Gaia, Pinter, Andreas

Volltext

Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA von Blauvelt, Andrew, Garrelts, Alyssa, Malatestinic, William, Birt, Julie, Zhu, Baojin, Feely, Meghan

Volltext

Disease burden among patients with atopic dermatitis treated with systemic therapy for 4–12 months: results from the CorEvitas Atopic Dermatitis Registry von Silverberg, Jonathan I., Pierce, Evangeline, Feely, Meghan, Atwater, Amber Reck, Schrader, Amy, Jones, Eric A., Dave, Swapna S., Simpson, Eric L.

Volltext

51202 Effectiveness of Biologics in Clinical Practice: Interim Month 24 Results from the International Observational Psoriasis Study of Health Outcomes (PSoHO) von Armstrong, April W., Maul, Julia-Tatjana, Costanzo, Antonio, Smith, Saxon D., Konicek, Bruce W., Feely, Meghan, Haustrup, Natalie, Lampropoulou, Anastasia, Brnabic, Alan, Pinter, Andreas

Volltext

52244 Early Improvement in Nail and Scalp Psoriasis from a Prospective Observational Study of Patients with Psoriasis in Special Areas (PSoSA) Initiating Ixekizumab: Results from t... von Bagel, Jerry, Dawes, Kenneth, Burgy, Jessica, Herman, Edward, Feely, Meghan, Vadhariya, Aisha, Malatestinic, William N., See, Kyoungah, Zhu, Baojin, Merola, Joseph F.

Volltext

33273 Impact of atopic dermatitis lesion locations on patient burden: A real-world study von Lio, Peter, Simpson, Eric, Pierce, Evangeline, Cronin, Angel, McLean, Robert, Dave, Swapna S., Kovacik, Amy J., Feely, Meghan, Silverberg, Jonathan

Volltext

Autonomous seawater pCO2 and pH time series from 40 surface buoys and the emergence of anthropogenic trends von Adrienne J Sutton, Feely, Richard A, Maenner-Jones, Stacy, Musielwicz, Sylvia, Osborne, John, Dietrich, Colin, Monacci, Natalie, Cross, Jessica, Bott, Randy, Kozyr, Alex, Andersson, Andreas J, Bates, Nicholas R, Wei-Jun, Cai, Cronin, Meghan F, De Carlo, Eric H, Hales, Burke, Howden, Stephan D, Lee, Charity M, Manzello, Derek P, McPhaden, Michael J, Meléndez, Melissa, Mickett, John B, Newton, Jan A, Noakes, Scott E, Noh, Jae Hoon, Olafsdottir, Solveig R, Joseph E Salisbury, Send, Uwe, Trull, Thomas W, Vandemark, Douglas C, Weller, Robert A

Volltext

43113 Ixekizumab improves fatigue, an important patient-reported outcome in psoriasis von Merola, Joseph, Gladman, Dafna, Tahir, Hasan, Boehncke, Wolf-Henning, Garrelts, Alyssa, See, Kyoungah, McKean-Matthews, Missy, Feely, Meghan, Bolce, Rebecca, Birt, Julie, Strand, Vibeke

Volltext

42276 Long-Term Safety of Ixekizumab Treatment in Adult Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: A Post-hoc Analysis of End-Of-Study Program Data R... von Lebwohl, Mark, Deodhar, Atul, Schwartzman, Sergio, Salvarani, Carlo, Feely, Meghan, Zhu, Danting, Rahman, Proton, Papp, Kim A., Merola, Joseph F., Gottlieb, Alice, Blauvelt, Andrew

Volltext

41602 Achievement of National Psoriasis Foundation (NPF) treatment targets and acceptable responses among patients with psoriasis treated with ixekizumab versus other biologics in... von Armstrong, April, Blauvelt, Andrew, Papp, Kim A., Green, Lawrence J., Feely, Meghan, Malatestinic, William N., See, Kyoungah, McKean-Matthews, Missy, Strober, Bruce E.

Volltext